Flow Cytometry in the Diagnosis of Canine T-Cell Lymphoma.
T-cell
diagnosis
dog
flow cytometry
lymphoma
prognosis
Journal
Frontiers in veterinary science
ISSN: 2297-1769
Titre abrégé: Front Vet Sci
Pays: Switzerland
ID NLM: 101666658
Informations de publication
Date de publication:
2021
2021
Historique:
received:
31
08
2020
accepted:
26
02
2021
entrez:
10
5
2021
pubmed:
11
5
2021
medline:
11
5
2021
Statut:
epublish
Résumé
T cell lymphoma (TCL) is a heterogenous group of lymphoid malignancies representing about 30-40% of all canine lymphomas and often harboring a very aggressive behavior. WHO classification identifies the majority of TCLs as peripheral TCL, but other subtypes with peculiar presentation and outcome have been recognized. This review aims to explore the use of flow cytometry for refining the diagnosis of canine TCL, putting a particular emphasis on the identification of some peculiar immunotypes, such as T zone lymphoma; on the investigation of putative prognostic markers; and on the evaluation of lymphoma stage and of the minimal residual disease.
Identifiants
pubmed: 33969027
doi: 10.3389/fvets.2021.600963
pmc: PMC8096896
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
600963Informations de copyright
Copyright © 2021 Comazzi and Riondato.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Vet Intern Med. 2014 Mar-Apr;28(2):538-46
pubmed: 24495161
Vet Pathol. 2013 Jul;50(4):693-703
pubmed: 23125145
Vet Pathol. 2011 Jan;48(1):198-211
pubmed: 20861499
Vet Pathol. 2018 Mar;55(2):241-244
pubmed: 29343197
Vet Comp Oncol. 2019 Jun;17(2):139-146
pubmed: 30578621
J Vet Diagn Invest. 2018 Nov;30(6):830-836
pubmed: 30264662
Vet Pathol. 2019 Nov;56(6):878-884
pubmed: 31170900
Vet Dermatol. 2009 Oct;20(5-6):569-76
pubmed: 20178496
Vet J. 2011 May;188(2):149-55
pubmed: 20413335
Immunology. 2011 Jan;132(1):111-22
pubmed: 20880379
J Vet Intern Med. 2013 Nov-Dec;27(6):1509-16
pubmed: 24112291
J Vet Intern Med. 2006 Sep-Oct;20(5):1161-5
pubmed: 17063710
Vet J. 2013 Sep;197(3):776-81
pubmed: 23735731
Vet Comp Oncol. 2020 Dec;18(4):656-663
pubmed: 32163214
Vet Immunol Immunopathol. 2008 Sep 15;125(1-2):102-10
pubmed: 18579219
Vet Clin Pathol. 2018 Dec;47(4):643-648
pubmed: 30229963
J Vet Med Sci. 2016 Sep 1;78(8):1237-44
pubmed: 27098109
Vet Pathol. 2000 Nov;37(6):637-46
pubmed: 11105953
Vet Immunol Immunopathol. 2005 Jul 15;106(3-4):179-96
pubmed: 15963817
Vet Comp Oncol. 2017 Jun;15(2):431-440
pubmed: 26792094
Vet Comp Oncol. 2019 Sep;17(3):253-264
pubmed: 30684308
Vet J. 2019 Apr;246:78-84
pubmed: 30902194
Vet Immunol Immunopathol. 2005 Apr 8;104(3-4):239-47
pubmed: 15734544
Vet Immunol Immunopathol. 2017 Sep;191:5-13
pubmed: 28895866
Vet Clin Pathol. 2016 Mar;45(1):172-8
pubmed: 26709607
Vet J. 2004 Mar;167(2):158-66
pubmed: 14975390
Vet Clin Pathol. 2020 Jun;49(2):307-311
pubmed: 32347563
Vet Pathol. 2013 Sep;50(5):738-48
pubmed: 23444036
Vet Comp Oncol. 2013 Dec;11(4):272-86
pubmed: 22296667
J Vet Intern Med. 2014 May-Jun;28(3):878-86
pubmed: 24655022
Vet Clin Pathol. 2019 Mar;48(1):5-6
pubmed: 30811611
Vet Clin Pathol. 2015 Mar;44(1):58-69
pubmed: 25512102
Vet Pathol. 2013 Mar;50(2):281-90
pubmed: 22711745
Vet Comp Oncol. 2016 Aug;14 Suppl 1:117-26
pubmed: 26040658
J Vet Diagn Invest. 2020 Nov;32(6):918-922
pubmed: 32814519
Vet Comp Oncol. 2015 Sep;13(3):281-7
pubmed: 23721515
J Comp Pathol. 2018 May;161:34-42
pubmed: 30173856
J Vet Med Sci. 2017 Apr 8;79(4):736-739
pubmed: 28302939
Vet Comp Oncol. 2015 Dec;13(4):475-80
pubmed: 24341365
Crit Rev Oncol Hematol. 2011 Sep;79(3):330-43
pubmed: 21273093
BMC Vet Res. 2019 Nov 16;15(1):413
pubmed: 31733649
Cancer Res. 2005 Jul 1;65(13):5654-61
pubmed: 15994938
Vet Comp Oncol. 2020 Sep;18(3):416-427
pubmed: 31951040
Vet Immunol Immunopathol. 2008 Feb 15;121(3-4):179-88
pubmed: 17981339
Vet Pathol. 2010 May;47(3):414-33
pubmed: 20472804
Annu Rev Immunol. 2000;18:975-1026
pubmed: 10837080